Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tempei Miyaji

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
BMJ Open|February 8, 2022
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocolHiromichi Matsuoka, Katherine Clark, Belinda Fazekas, et al.
Journal of Pain and Symptom Management|June 30, 2019
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08)Hiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2019
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) studyHiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, et al.
BMJ Open|February 16, 2021
Protocol for a multicentre, prospective, cohort study to investigate patient satisfaction and quality of life after immediate breast reconstruction in Japan: the SAQLA studyMiho Saiga, Yuko Hosoya, Hiroki Utsunomiya, et al.
British Journal of Cancer|November 17, 2023
Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)Hiroko Minatogawa, Naoki Izawa, Kazuhiro Shimomura, et al.
Psychiatry and Clinical Neurosciences|March 12, 2024
Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J-SUPPORT 2001 Study)Tatsuo Akechi, Toshiaki A Furukawa, Hisashi Noma, et al.
JAMA|May 17, 2022
Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics GuidelinesSamantha Cruz Rivera, Olalekan Lee Aiyegbusi, Jonathan Ives, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
BMJ Open|February 8, 2022
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocolHiromichi Matsuoka, Katherine Clark, Belinda Fazekas, et al.
Journal of Pain and Symptom Management|June 30, 2019
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08)Hiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2019
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) studyHiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, et al.
BMJ Open|February 16, 2021
Protocol for a multicentre, prospective, cohort study to investigate patient satisfaction and quality of life after immediate breast reconstruction in Japan: the SAQLA studyMiho Saiga, Yuko Hosoya, Hiroki Utsunomiya, et al.
British Journal of Cancer|November 17, 2023
Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)Hiroko Minatogawa, Naoki Izawa, Kazuhiro Shimomura, et al.
Psychiatry and Clinical Neurosciences|March 12, 2024
Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J-SUPPORT 2001 Study)Tatsuo Akechi, Toshiaki A Furukawa, Hisashi Noma, et al.
JAMA|May 17, 2022
Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics GuidelinesSamantha Cruz Rivera, Olalekan Lee Aiyegbusi, Jonathan Ives, et al.
Pageof 6